Akebia Therapeutics (NASDAQ: AKBA)
Akebia Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Akebia Therapeutics Company Info
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
News & Analysis
Why Shares of Akebia Therapeutics Were Up Tuesday
An approval in the U.K. for Akebia's symptomatic anemia therapy boosted the stock.
Why Akebia Therapeutics Stock Is Soaring Today
Investors liked what they heard in the company's Q2 update.
Why Akebia Therapeutics Stock Is Plunging Today
Investors were not impressed with the drugmaker's latest quarterly update.
Why Akebia Therapeutics Stock Is Crashing Today
The company's lead pipeline candidate fell short in a late-stage clinical study.
Why Akebia Therapeutics Stock Is Crushing It Today
The biotech reported great news for its lead pipeline candidate.
2 Small-Cap Stocks That Could Double Your Money
Akebia Therapeutics and Satsuma Pharmaceuticals could both be big winners for early shareholders.
Why Akebia Therapeutics Stock Sank Today
The biotech provided a disappointing Q4 update.
Why Akebia Therapeutics Stock Is Jumping Today
Momentum is continuing for the biotech after an announcement of positive clinical results and buying by key insiders earlier this month.
Valuation
Earnings Transcripts
Akebia Therapeutics, inc (AKBA) Q3 2021 Earnings Call Transcript
AKBA earnings call for the period ending September 30, 2021.
Akebia Therapeutics, inc (AKBA) Q2 2021 Earnings Call Transcript
AKBA earnings call for the period ending June 30, 2021.
Akebia Therapeutics Inc (AKBA) Q3 2020 Earnings Call Transcript
AKBA earnings call for the period ending September 30, 2020.
Akebia Therapeutics Inc (AKBA) Q1 2020 Earnings Call Transcript
AKBA earnings call for the period ending March 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.